ClinicalTrials.Veeva

Menu

Urinary Markers of Detrusor Overactivity in Spina Bifida Patients (BUHD-SPINA)

R

Rennes University Hospital

Status

Completed

Conditions

Spina Bifida
Multiple Sclerosis
Spinal Cord Injury
Overactive Bladder

Study type

Observational

Funder types

Other

Identifiers

NCT02852317
35RC14_8805

Details and patient eligibility

About

The purpose of this study is to assess diagnostic performance of urinary markers of detrusor overactivity (Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), adenosine triphosphate (ATP), Prostaglandine E2) in detected high pressure bladder un spina bifida patients.

Enrollment

134 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Study arm:

  • Spina bifida patient
  • Seen consecutively in outpatient clinics
  • Age > 18 years-old

Control arm:

  • Patients with multiple sclerosis or spinal cord injury or overactive bladder
  • Seen consecutively in urodynamics
  • with lower urinary tract symptoms
  • Age > 18 years-old

Exclusion criteria

  • Positive urine culture
  • History of urologic neoplasms
  • History of interstitial cystitis

Trial design

134 participants in 4 patient groups

Spina bifida patient
Patients with multiple sclerosis
Patients with spinal cord injury
Patients with overactive bladder

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems